The Story
Born in Sri Lanka, shaped by Britain and deeply connected to Switzerland through family and life. A PhD scientist who became a commercial leader, and the adviser CEOs and boards bring in when the problem is sensitive, cross-functional and too important to force into a standard methodology.
The through-line
For more than two decades that was the real job, whatever the title said. I ran multi-million-pound global accounts, led delivery teams across time zones, and sat across the table from board-level executives at some of the world's largest companies. The figures were big. The real work was listening beyond the official explanation, following the money across organisational boundaries and holding trust where the stakes were highest.
The same pattern repeated in every organisation. Capable people held different pieces of the same answer, with no route to the decision-maker. Expensive dysfunction had been normalised because it was distributed. I built the operating systems that made the truth visible and usable: partnership and client excellence programmes, governance that turned messy high-value relationships into something measurable, and an early-warning system in a large pharmaceutical portfolio that protected approximately £15 million in its first year and continued after I left.
Then I made a deliberate decision: go deep on AI, not as an observer but as a builder. I have designed, built and shipped AI platforms of my own, including raretrial.org, Royal Author and AreaIQ, so when I say the fix can be made to work, that is not a slide. It is a capability I can prove. I hold a PhD in Chemistry and an Executive MBA, which means I can move between the technical detail a system demands and the commercial consequence a board must act on.
The Journey
Moving between cultures, industries, disciplines and rooms trains you to notice what insiders miss: the assumptions a system no longer questions.
1983 · The beginning
An intense education, chemistry, and the earliest version of the habit that defines the work now: refusing to accept the first explanation.
2003 · A life across borders
At twenty I left Sri Lanka. What followed was a life lived between cultures: married into Switzerland, at home in Britain, working across the world. Moving between rooms trains a particular skill: seeing the signals lost between functions, and the possibilities visible only from another vantage point.
The training
A PhD in Chemistry and an Executive MBA. A scientist who became a commercial leader: trained to follow evidence rather than opinion, to test contradictions, and to move between molecular detail and enterprise consequence without losing either.
Two decades in the room
Most of those years in life sciences and pharma: multi-million-pound partnerships, large delivery teams, board-level trust. And in every organisation, the same discovery. The answer was already inside the business; it simply could not travel. In one large pharmaceutical portfolio, the early-warning system I built protected approximately £15 million in its first year and continued after I left.
2023 · The author
A leadership book drawn from Queen Elizabeth II's seventy-year reign, and four international awards. Long before it became a title, "a job well done" described the standard I tried to create inside organisations: people understood the goal, saw how they contributed and could take pride in the result.
2025 · The turn to AI
A deliberate decision to go deep on applied AI and build with it. raretrial.org makes 500,000+ clinical trials searchable in plain English. Royal Author, AreaIQ and a portfolio of purpose-built platforms. Proof that when a diagnosis requires a mechanism, I can create it, not merely recommend it.
Now
I work personally with CEOs, boards and investors to uncover what their organisations cannot see about themselves, and to architect the systems that change what happens next. The book that names the category, The Enterprise Blind Spot, is coming in 2027. And the same intelligence now serves a second deliberately chosen mission: helping mothers build future security.
The Credentials
Academic
A PhD in Chemistry and an Executive MBA. A scientist who became a commercial leader: the rigour to follow evidence wherever it leads, and the commercial training to state what it costs and what to do about it.
Author
Four international awards. Stocked and read globally. A leadership book drawn from Queen Elizabeth II's 70-year reign, and the authority asset that proved expertise could have a life beyond the organisations it was built inside.
Builder
AI platforms and tools including raretrial.org (500,000+ trials), royalauthor.com and AreaIQ: designed, built and launched personally. The practical proof that diagnosis does not have to end with a report: where the fix requires a mechanism, I can build it.
Speaker
Keynotes on enterprise blind spots, AI and human systems, and future security, delivered to organisations and leadership audiences internationally. The stage is where the thinking meets real resistance and answers it.
Who I Work With
For Organisations
For CEOs, boards, founders and investors. I personally investigate the problems intelligent teams have been unable to solve, reveal what they are costing, and architect the operating system, intervention or capability that changes what happens next.
For Mothers
The second deliberately chosen mission. I help ambitious mothers understand what is changing, use AI with confidence and turn their knowledge into something they own. Because when a mother becomes future-ready, an entire family moves forward.
Recognition
The Next Step
I work with a small number of CEOs, boards and investors each year. If something is happening in your organisation that should not be happening, describe it briefly and confidentially. I respond where I believe my involvement could create material value.
Request a Confidential Conversation